Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-07 Sale | 2024-05-09 4:10 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 236 | $7.76 | $1,831 | 11,571 (Direct) | View |
| 2024-03-08 Sale | 2024-03-08 6:05 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Vice President, Finance | 4,884 | $11.72 | $57,219 | 11,807 (Direct) | View |
| 2023-05-10 Sale | 2023-05-11 4:12 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 210 | $3.31 | $695 | 15,992 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-26 Option Award | 2024-01-30 9:10 pm | N/A 2034-01-25 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Vice President, Finance | 93,820 | $0 | 93,820 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller | 16,100 | $0 | 16,100 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 4:15 pm | N/A 2032-07-14 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller | 16,540 | $0 | 16,540 (Direct) | View |
| 2022-05-06 Option Award | 2022-05-10 4:15 pm | N/A 2032-05-05 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller | 9,750 | $0 | 22,702 (Direct) | View |
Ownership | 2022-03-14 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller | 0 | $0 | 35,906 (Direct) | View |